Sales ratio of core products declined

Published: 1998-04-08 16:21:00

Updated: 1998-04-08 16:21:00

According to an analysis of leading listed pharmaceutical firms having fiscal year ended at Dec. 31, the 1997 the sales of core products showed 729,200 million Won, which was 36.6% of the total sales of 1,999,200 million Won and 2.2% point lower than 1996 of 38.8%. (Total sales in 1996: ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK